Rho Guanine Nucleotide Exchange Factor 3 (ARHGEF3) Antibody
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
Rabbit Polyclonal against the ARHGEF3 protein.
Documents del producto
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Rho Guanine Nucleotide Exchange Factor 3 (ARHGEF3) |
| Host | Rabbit |
| Reactivity | Human |
| Recommended Dilution | ELISA: 1/20000 - 1/80000, WB: 1/500 - 1/2000, IHC: 1/100 - 1/200. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Purification | Purified by antigen affinity column chromatography. |
| Size 1 | 100 µg |
| Size 2 | 1 mg |
| Form | Lyophilized |
| Tested Applications | ELISA, WB, IHC |
| Buffer | Prior to lyophilization: 1% BSA and 0.02% NaN3. |
| Availability | Shipped within 7-15 working days. |
| Storage | Store at -20 °C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| Background | Antibody anti-ARHGEF3 |
| Status | RUO |
| Note | Concentration: Lyophilized form: Not applicable. After reconstitution: 1 mg/ml. - |
Descripción
Related Products
Rho Guanine Nucleotide Exchange Factor 3 (ARHGEF3) Antibody
ARHGEF3 Antibody is a Rabbit Polyclonal Antibody against ARHGEF3.
Ver Producto
Rho Guanine Nucleotide Exchange Factor 3 (ARHGEF3) Antibody
Rabbit polyclonal antibody against ARHGEF3 protein. Immunogen region is C-terminal.
Ver Producto
Rho Guanine Nucleotide Exchange Factor 3 (ARHGEF3) Antibody
Rho-like GTPases are involved in a variety of cellular processes, and they are activated by binding GTP and inactivated by conversion of GTP to GDP by their intrinsic GTPase activity. Guanine nucleotide exchange factors (GEFs) accelerate the GTPase activity of Rho GTPases by catalyzing their release of bound GDP. This gene encodes a guanine nucleotide exchange factor, which specifically activates two members of the Rho GTPase family: RHOA and RHOB, both of which have a role in bone cell biology. It has been identified that genetic variation in this gene plays a role in the determination of bone mineral density (BMD), indicating the implication of this gene in postmenopausal osteoporosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Ver Producto